Viewing StudyNCT00215826

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00215826
Status: COMPLETED
Last Update Posted: 2013-04-17
First Post: 2005-09-16
Brief Title: Study of Alferon LDO Low Dose Oral in Normal Volunteers
Sponsor: AIM ImmunoTech Inc
Organization: AIM ImmunoTech Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Severe Acute Respiratory Syndrome
Keywords:
Name View
Possible SARS View
SARS View
Alferon LDO View
Low Dose Oral Interferon ALFA-n3 View
Human Leukocyte Derived View
Exposure to SARS View